Literature DB >> 23901223

Influence of up-regulation of Notch ligand DLL4 on biological behaviors of human gastric cancer cells.

Guo-Gang Li1, Lan Li, Chao Li, Long-Yun Ye, Xiao-Wen Li, Da-Ren Liu, Qi Bao, Yi-Xiong Zheng, Da-Peng Xiang, Li Chen, Jian Chen.   

Abstract

AIM: To investigate the potential roles of Delta-like ligand 4 (DLL4) on the biological behavior of gastric cancer cells and its molecular mechanisms.
METHODS: A recombinant eukaryotic expression vector containing human DLL4 gene was constructed and transfected into the human gastric cancer cell line SGC7901. Clones with up-regulated DLL4 were selected and amplified. The effect of DLL4 up-regulation on gastric cancer cell growth was assessed using cell growth assay. The migration and invasion were assessed using a transwell migration assay and matrigel invasion assay. Matrix metalloproteinases were detected using the zymogram technique. Cells were implanted subcutaneously into male BALB/c nu/nu mice. Tumor volumes were then calculated and compared. DLL4 staining in the implanted tumor was performed using immunohistochemistry technique.
RESULTS: Growth curves over a six-day time course showed significantly promoted cell proliferation of SGC7901 cells with up-regulated DLL4. DLL4 up-regulation in SGC7901 cells promoted the migration (205.4 ± 15.2 vs 22.3 ± 12.1, P < 0.05) and invasion (68.8 ± 5.3 vs 18.2 ± 6.0, P < 0.05) in vitro and tumorigenicity in vivo (2640.5 ± 923.6 mm(3) vs 1115.1 ± 223.8 mm(3), P < 0.05). Furthermore, significantly increased mRNA level and increased secretion of matrix metalloproteinase-2 (MMP-2) proenzyme were observed in SGC7901 cells with up-regulated DLL4. However, increased MMP-9 mRNA level but decreased extracellular MMP-9 proenzyme level was observed.
CONCLUSION: Our observations indicated a mechanism by which activation of DLL4-mediated Notch signaling promotes the expression and secretion of MMP-2 proenzyme and influences the progress of gastric cancer.

Entities:  

Keywords:  Delta-like ligand 4/Notch; Gastric cancer; Invasion; Matrix metalloproteinase; Migration

Mesh:

Substances:

Year:  2013        PMID: 23901223      PMCID: PMC3725372          DOI: 10.3748/wjg.v19.i28.4486

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  35 in total

1.  Cross-talk between endothelial cells and tumor via delta-like ligand 4/Notch/PTEN signaling inhibits lung cancer growth.

Authors:  X-Y Ding; J Ding; K Wu; W Wen; C Liu; H-X Yan; C Chen; S Wang; H Tang; C-K Gao; L-N Guo; D Cao; Z Li; G-S Feng; H-Y Wang; Z-F Xu
Journal:  Oncogene       Date:  2011-10-17       Impact factor: 9.867

Review 2.  Current status of chemoradiotherapy for gastric cancer in Japan.

Authors:  Toshimasa Tsujinaka; Kazumasa Fujitani; Motohira Hirao; Yukimori Kurokawa
Journal:  Int J Clin Oncol       Date:  2008-05-08       Impact factor: 3.402

3.  MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer.

Authors:  J Mrena; J-P Wiksten; S Nordling; A Kokkola; A Ristimäki; C Haglund
Journal:  J Clin Pathol       Date:  2006-06       Impact factor: 3.411

4.  Notch signaling induces cell cycle arrest in small cell lung cancer cells.

Authors:  V Sriuranpong; M W Borges; R K Ravi; D R Arnold; B D Nelkin; S B Baylin; D W Ball
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

5.  Blockade of delta-like ligand 4 signaling inhibits both growth and angiogenesis of pancreatic cancer.

Authors:  Hidekazu Oishi; Makoto Sunamura; Shinichi Egawa; Fuyuhiko Motoi; Michiaki Unno; Toru Furukawa; Nagy A Habib; Hideo Yagita
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

6.  DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency.

Authors:  Timothy Hoey; Wan-Ching Yen; Fumiko Axelrod; Jesspreet Basi; Lucas Donigian; Scott Dylla; Maureen Fitch-Bruhns; Sasha Lazetic; In-Kyung Park; Aaron Sato; Sanjeev Satyal; Xinhao Wang; Michael F Clarke; John Lewicki; Austin Gurney
Journal:  Cell Stem Cell       Date:  2009-08-07       Impact factor: 24.633

7.  gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity.

Authors:  Raymond D Meng; Christopher C Shelton; Yue-Ming Li; Li-Xuan Qin; Daniel Notterman; Philip B Paty; Gary K Schwartz
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

8.  The activated Notch1 signal pathway is associated with gastric cancer progression through cyclooxygenase-2.

Authors:  Tien-Shun Yeh; Chew-Wun Wu; Kai-Wen Hsu; Wan-Jung Liao; Min-Chieh Yang; Anna Fen-Yau Li; An-Ming Wang; Min-Liang Kuo; Chin-Wen Chi
Journal:  Cancer Res       Date:  2009-06-02       Impact factor: 12.701

9.  Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501.

Authors:  Takeshi Sano; Mitsuru Sasako; Seiichiro Yamamoto; Atsushi Nashimoto; Akira Kurita; Masahiro Hiratsuka; Toshimasa Tsujinaka; Taira Kinoshita; Kuniyoshi Arai; Yoshitaka Yamamura; Kunio Okajima
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

10.  Distinct effects of the soluble versus membrane-bound forms of the notch ligand delta-4 on human CD34+CD38low cell expansion and differentiation.

Authors:  Medhi Lahmar; Cyril Catelain; Sonia Poirault; Marion Dorsch; Jean-Luc Villeval; William Vainchenker; Olivier Albagli; Evelyne Lauret
Journal:  Stem Cells       Date:  2007-11-29       Impact factor: 6.277

View more
  11 in total

1.  Hypoxia regulates CD44 expression via hypoxia-inducible factor-1α in human gastric cancer cells.

Authors:  Gai Liang; Shuang Li; Wei Du; Qinghua Ke; Jun Cai; Jiyuan Yang
Journal:  Oncol Lett       Date:  2016-12-08       Impact factor: 2.967

2.  Inhibition of Delta-like Ligand 4 enhances the radiosensitivity and inhibits migration in cervical cancer via the reversion of epithelial-mesenchymal transition.

Authors:  Shan-Shan Yang; De-Yang Yu; Yu-Ting Du; Le Wang; Lina Gu; Yun-Yan Zhang; Min Xiao
Journal:  Cancer Cell Int       Date:  2020-07-28       Impact factor: 5.722

3.  DLL4 as a predictor of pelvic lymph node metastasis and a novel prognostic biomarker in patients with early-stage cervical cancer.

Authors:  Shanshan Yang; YunDuo Liu; BaiRong Xia; Jiangpeng Deng; TianBo Liu; Qi Li; YanPing Yang; YaoXian Wang; XiaoMing Ning; YunYan Zhang; Min Xiao
Journal:  Tumour Biol       Date:  2015-11-06

4.  MSX1 induces G0/G1 arrest and apoptosis by suppressing Notch signaling and is frequently methylated in cervical cancer.

Authors:  Yujuan Yue; Kun Zhou; Jiachu Li; Shan Jiang; Chunyan Li; Haitao Men
Journal:  Onco Targets Ther       Date:  2018-08-10       Impact factor: 4.147

5.  Concurrent Treatment with Anti-DLL4 Enhances Antitumor and Proapoptotic Efficacy of a γ-Secretase Inhibitor in Gastric Cancer.

Authors:  Muxing Kang; Yaoyi Zhang; Xiaoli Jin; Guofeng Chen; Yi Huang; Dan Wu; Guogang Li; Jianzhen Shan; Pintong Huang; Jian Chen
Journal:  Transl Oncol       Date:  2018-03-16       Impact factor: 4.243

Review 6.  The Role of DLLs in Cancer: A Novel Therapeutic Target.

Authors:  Meng-Xi Xiu; Yuan-Meng Liu; Bo-Hai Kuang
Journal:  Onco Targets Ther       Date:  2020-05-07       Impact factor: 4.147

Review 7.  Notch signalling pathway as an oncogenic factor involved in cancer development.

Authors:  Marlena Brzozowa-Zasada; Adam Piecuch; Anna Dittfeld; Łukasz Mielańczyk; Marek Michalski; Grzegorz Wyrobiec; Marzena Harabin-Słowińska; Józef Kurek; Romuald Wojnicz
Journal:  Contemp Oncol (Pozn)       Date:  2016-09-05

Review 8.  The role of Notch signaling in gastric carcinoma: molecular pathogenesis and novel therapeutic targets.

Authors:  Yizheng Yao; Ying Ni; Jiawen Zhang; Hua Wang; Shihe Shao
Journal:  Oncotarget       Date:  2017-05-11

9.  Endothelial Dll4 overexpression reduces vascular response and inhibits tumor growth and metastasization in vivo.

Authors:  Alexandre Trindade; Dusan Djokovic; Joana Gigante; Liliana Mendonça; António Duarte
Journal:  BMC Cancer       Date:  2017-03-14       Impact factor: 4.430

10.  Evaluation of the correlation of vasculogenic mimicry, Notch4, DLL4, and KAI1/CD82 in the prediction of metastasis and prognosis in non-small cell lung cancer.

Authors:  Yichao Wang; Ruixue Yang; Xiaolin Wang; Hongfei Ci; Lei Zhou; Bo Zhu; Shiwu Wu; Danna Wang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.